side effects semaglutide vs tirzepatide vs. Tirzepatide: Which is Right for You? Semaglutide vs Tirzepatide for Weight

Wagner, N

Retatrutide Phase 3 (ADA 2026) Key Updates at a Glance By Eli Lilly and Company Retatrutide continues to position itself as one of the most potent obesity therapies in development, demonstrating substantial weight loss while simultaneously improving multiple obesity-related complications

It acts as a buffer to maintain pH stability

If one of my patients tells me they are tired or exhausted, my first thought is to look at their mitochondrial function because I know its the major player for many diseases

A 2022 meta-analysis in JAMA (N=7,234 across 10 randomized trials) found that GLP-1 agonist discontinuation rates due to gastrointestinal adverse events ranged from 4.5% to 8.7% depending on titration speed [7]

10.1016/j.coph.2006.08.011 Curr